Silver Book Fact

During the past decade, growth of spending for prostate cancer has averaged 11 percent a year, outpacing rates for other common conditions such as cardiovascular and pulmonary diseases. 

Jacobs B, Zhang Y, Skolarus T, Hollenbeck B. Growth Of High-Cost Intensity-Modulated Radiotherapy For Prostate Cancer Raises Concerns About Overuse. Health Affairs. 2012; 31(4): 750-759

Reference

Title
Growth Of High-Cost Intensity-Modulated Radiotherapy For Prostate Cancer Raises Concerns About Overuse
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2012
Authors
Jacobs B, Zhang Y, Skolarus T, Hollenbeck B
Volume & Issue
Volume 31, Issue 4
Pages
750-759

Categories

  • Cost of Disease
  • Prevalence & Incidence

Related Facts

  • The total cost of cancer in the U.S. is projected to increase from $290 billion in 2010 to $458 billion in 2030.  
  • Costs for cancer therapy, which reached $104 billion in 2006, are now projected to rise to $173 billion in 2020.  
  • In 2007, an estimated 218,890 men will be diagnosed with prostate cancer.  
  • More than one in four cancer survivors have a high burden from their symptoms at one-year after their diagnosis–even those who are no longer getting treatment.  
  • Breast cancer is 100 times more common in women than in men.